A medicine commonly used to treat intestinal worm infections has caught researchers’ attention for an unexpected reason. When combined with a targeted lung cancer drug, it helped slow the growth of tumors that had stopped responding to treatment in a study involving mice. The findings, published in PLOS ONE, raise an intriguing possibility for researchers …
Two existing cancer medications have caught researchers’ attention after experiments suggested they could help reverse some of the brain changes associated with Alzheimer’s disease. When scientists combined the drugs in mice, they observed reduced harmful protein buildup and improvements in learning and memory, offering a new direction in the search for treatments. The medications are …
A drug already carrying years of human safety data from trials for Parkinson’s disease and ALS just produced a striking result in a different disease altogether. Researchers at Monash University gave the compound to mice bred to develop Alzheimer’s, then watched what happened inside the animals’ brains over eight weeks of treatment. Numbers from that …